Elderberry: Clinical Evidence & Substantiation Summary

Clinical Trials
14
Strongest Evidence
Immune Function
Typical Dosage
300–600 mg/day (extract) or 15 mL/day (syrup)
Common Forms
Standardised elderberry extract

What Is Elderberry?

Elderberry (Sambucus nigra) extract is one of the most popular immune-support botanicals, with clinical evidence supporting its use for reducing the duration and severity of upper respiratory infections, particularly colds and influenza.

Mechanism of action: Elderberry's anthocyanins and other flavonoids exhibit direct antiviral activity by inhibiting viral adhesion and entry into host cells. They also stimulate cytokine production (IL-6, IL-8, TNF-α), enhancing innate immune response, while modulating pro-inflammatory pathways.

Clinical Evidence Summary

Below are 5 key clinical studies on Elderberry. Nutra Comp analyses 14+ studies in its full clinical evidence report.

Meta-analysis2019PMID: 30670267

Black elderberry supplementation for upper respiratory symptoms: a meta-analysis

Population: 4 RCTs, 180 participants

Key finding: Elderberry supplementation significantly reduced upper respiratory symptom duration (mean reduction: 2.1 days, p<0.001) and severity.

RCT, double-blind2017PMID: 28515951

Elderberry extract and influenza: a randomised trial

Population: 312 air travellers

Key finding: Elderberry extract significantly reduced cold episode duration (4.75 vs 6.88 days, p=0.02) and severity in travellers.

Laboratory study + clinical review2018PMID: 30163680

In vitro antiviral activity of elderberry extract

Population: Multiple viral strains

Key finding: Elderberry extract demonstrated inhibition of influenza A and B virus replication at extract concentrations achievable with standard supplementation.

Elderberry and immune biomarkers in humans

Population: 52 healthy adults

Key finding: Elderberry extract (600 mg/day for 10 days) significantly increased antibody titers against influenza following vaccination (p=0.04).

Systematic review2019PMID: 31691193

Safety and tolerability of elderberry supplementation

Population: All available clinical data

Key finding: Elderberry supplementation demonstrated excellent safety and tolerability at standard doses, with adverse events comparable to placebo.

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

8
Supports healthy immune system function
Category: Immune · Confidence: 8/10
7
Provides antioxidant support through anthocyanin content
Category: Antioxidant · Confidence: 7/10
7
Supports upper respiratory health during seasonal challenges
Category: Respiratory · Confidence: 7/10

Get the full substantiation report for Elderberry

Includes all 14+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Vitamin D3
127 studies · Bone Health & Calcium Metabolism
Zinc
92 studies · Immune Function
Vitamin C
168 studies · Immune Function

Key Terms

Structure–Function ClaimRandomised Controlled Trial (RCT)Meta-Analysis

Frequently Asked Questions

Is elderberry FDA approved?

Elderberry is sold as a dietary supplement and does not require FDA approval. Raw elderberries should never be consumed uncooked due to cyanogenic glycoside content; commercial extracts are heat-processed.

What are the most studied benefits?

The strongest evidence supports elderberry for reducing the duration and severity of upper respiratory infections, particularly colds and influenza.

What dosage is used?

Most studies use 300–600 mg/day of standardised extract or 15 mL/day of syrup for prevention, with higher doses (4× daily) during acute symptoms.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist